XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated
Deficit
Accumulated
Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2019     46,189,870          
Beginning balance at Dec. 31, 2019 $ (42,279)   $ 5 $ 1,194,327   $ 3 $ (1,236,614)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (87,823)              
Unrealized gain (loss) from available-for-sale securities 79         79    
Vesting of restricted shares (in shares)     242,974          
Vesting of restricted shares 0              
Issuance of common stock upon purchase by employee stock purchase plan (in shares)     115,357          
Issuance of common stock upon purchase by employee stock purchase plan 1,621     1,621        
Share-based compensation expense 19,821     19,821        
Ending balance (in shares) at Sep. 30, 2020     46,548,201          
Ending balance at Sep. 30, 2020 (108,581)   $ 5 1,215,769   82 (1,324,437)  
Beginning balance (in shares) at Dec. 31, 2019     46,189,870          
Beginning balance at Dec. 31, 2019 (42,279)   $ 5 1,194,327   3 (1,236,614)  
Ending balance (in shares) at Dec. 31, 2020     46,779,479          
Ending balance at Dec. 31, 2020 $ (123,659) $ (86,433) $ 5 1,222,137 $ (134,450) 21 (1,345,822) $ 48,017
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06              
Beginning balance (in shares) at Jun. 30, 2020     46,448,491          
Beginning balance at Jun. 30, 2020 $ (109,419)   $ 5 1,208,616   108 (1,318,148)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (6,289)           (6,289)  
Unrealized gain (loss) from available-for-sale securities (26)         (26)    
Vesting of restricted shares (in shares)     39,650          
Vesting of restricted shares 0              
Issuance of common stock upon purchase by employee stock purchase plan (in shares)     60,060          
Issuance of common stock upon purchase by employee stock purchase plan 631     631        
Share-based compensation expense 6,522     6,522        
Ending balance (in shares) at Sep. 30, 2020     46,548,201          
Ending balance at Sep. 30, 2020 (108,581)   $ 5 1,215,769   82 (1,324,437)  
Beginning balance (in shares) at Dec. 31, 2020     46,779,479          
Beginning balance at Dec. 31, 2020 (123,659) $ (86,433) $ 5 1,222,137 $ (134,450) 21 (1,345,822) $ 48,017
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (54,592)           (54,592)  
Unrealized gain (loss) from available-for-sale securities (21)         (21)    
Vesting of restricted shares (in shares)     243,989          
Vesting of restricted shares 0              
Exercise of options (in shares)     195,758          
Exercise of options 3,805     3,805        
Issuance of common stock upon purchase by employee stock purchase plan (in shares)     106,767          
Issuance of common stock upon purchase by employee stock purchase plan 1,154     1,154        
Share-based compensation expense 17,197     17,197        
Ending balance (in shares) at Sep. 30, 2021     47,325,993          
Ending balance at Sep. 30, 2021 (242,549)   $ 5 1,109,843   0 (1,352,397)  
Beginning balance (in shares) at Mar. 31, 2021     47,255,094          
Beginning balance at Mar. 31, 2021 (227,077)   $ 5 1,103,282   0 (1,330,364)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (22,033)           (22,033)  
Unrealized gain (loss) from available-for-sale securities 0              
Vesting of restricted shares (in shares)     30,350          
Vesting of restricted shares 0              
Exercise of options (in shares)     83          
Exercise of options 1     1        
Share-based compensation expense 6,083     6,083        
Ending balance (in shares) at Jun. 30, 2021     47,325,993          
Ending balance at Jun. 30, 2021 (242,549)   $ 5 1,109,843   0 (1,352,397)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (22,033)              
Unrealized gain (loss) from available-for-sale securities 0              
Issuance of common stock upon purchase by employee stock purchase plan (in shares)     40,466          
Issuance of common stock upon purchase by employee stock purchase plan 477     477        
Ending balance (in shares) at Sep. 30, 2021     47,325,993          
Ending balance at Sep. 30, 2021 $ (242,549)   $ 5 $ 1,109,843   $ 0 $ (1,352,397)